Day: June 26, 2025

LIMERICK, Ireland, June 26, 2025 (GLOBE NEWSWIRE) — kneat.com, inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a leading healthcare technology and diagnostics company (“the Company”) has signed a multi-year Master Services Agreement with Kneat. The Company, which is headquartered in the United States, employs over 50,000 people and manufactures in more than a dozen countries worldwide. This manufacturer of medical technology, including medical devices and pharmaceutical diagnostics, will use the Kneat Gx platform initially to digitize its Commissioning, Qualification and Validation workflows for facilities, equipment and computer systems at several lead manufacturing sites. “After an extensive evaluation process this global leader selected...

VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) — Almaden Minerals Ltd. (“Almaden” or the “Company”; TSX: AMM; OTCQB: AAUAF) is pleased to announce the results of its Annual General and Special Meeting (“AGSM”) held on June 26, 2025. All of the matters submitted to the shareholders for approval as set out in the Company’s Notice of Meeting and Information Circular were approved by the requisite majority of votes cast at the AGSM. The details of the voting results for the election of directors are set out below:Nominee Votes For Votes WithheldDuane Poliquin 41,537,713 (94.02%) 2,640,240 (5.98%)Morgan Poliquin 44,037,858 (99.68%) 140,095 (0.32%)Alfredo Phillips 44,057,781 (99.73%) 120,172 (0.27%)Kevin O’Kane 44,047,973 (99.71%) 129,980 (0.29%)Michael Kosowan 44,057,926 (99.73%) 120,027 (0.27%) A...

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, June 26, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) announces that today it has completed its previously announced conversion (the “Transaction”) of an unsecured demand loan of $1 million from an insider of the Company into a $1 million principal amount 3% unsecured convertible debenture that is due on June 26, 2030 (the “Debenture”). For further details on the terms of the Debenture, see the press release issued by the Company on June 18, 2025. The closing of the Transaction remains subject to the final approval of the TSX Venture Exchange. The Company also announces that at its Annual and Special Meeting of Shareholders held on June 25, 2025, all Resolutions were voted 98% or higher...

VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (TSX: WPRT / Nasdaq: WPRT) (“Westport” or “The Company”) announces that the Company will release Q2 2025 financial results on Monday, August 11, 2025, after market close. A conference call and webcast to discuss the financial results and other corporate developments will be held on Tuesday, August 12, 2025. Time: 10:00 a.m. ET (7:00 a.m. PT)Call Link: https://register-conf.media-server.com/register/BI842f3b76bd5b44c7aee3e609a6cc77b3Webcast: https://investors.westport.com Participants may register up to 60 minutes before the event by clicking on the call link and completing the online registration form. Upon registration, the user will receive dial-in info and a unique PIN, along with an email confirming the details. The webcast will be archived...

TORONTO, June 26, 2025 (GLOBE NEWSWIRE) — Stack Capital Group Inc., (“Stack Capital”) (TSX:STCK & TSX:STCK.WT.A) is pleased to announce that at its annual meeting of shareholders, held virtually today, the four director nominees listed in Stack Capital’s management proxy circular dated May 13, 2025 (the “Circular”) were elected as directors of Stack Capital. Directors have been elected to serve until the close of the next annual meeting of shareholders. The detailed results of the vote are as follows:Nominee Votes For % Votes For Votes Against % Votes AgainstJohn K. Bell 4,564,900 99.71% 13,102 0.29%Jeffrey Parks 4,577,602 99.99% 400 0.01%Laurie Goldberg 3,518,191 76.85% 1,059,811 23.15%Gerri Sinclair 3,518,091 76.85% 1,059,911 23.15%         * The number of votes disclosed reflects shareholders voting...

TORONTO, June 26, 2025 (GLOBE NEWSWIRE) — NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to announce results from its 2025 Annual General and Special Meeting of Shareholders (the “Meeting”) held earlier today. A total of 50,604,879 common shares (“Shares”) were voted in person or represented by proxy at the Meeting, representing approximately 32.11% of the votes attached to all the outstanding Shares as at the record date of the Meeting. Election of DirectorsAt the Meeting, all nominees listed in the Company’s management information circular dated May 12, 2025 were elected as directors of the Company to serve until the next annual meeting of shareholders or until their successors are elected or appointed. Shareholders present in person or represented by proxy at the Meeting voted as follows:  Number...

TEL AVIV, Israel, June 26, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q2 2025 Aide Memoire is available on the “Investors” page on its website. Q2 2025 Aide Memoire Teva has prepared this document to assist in the financial modeling of its quarterly results. The document is based on Teva’s prior results, management’s previous commentary about Teva’s business outlook and data from select independent sources. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, Teva’s commitment to bettering health has never wavered. Today, the company’s global network of capabilities...

First-in-human trial of AX-0810 will evaluate safety, tolerability, pharmacokinetics, and target engagement in healthy volunteers with initial data expected in Q4 2025 Marks the first submitted Clinical Trial Application (CTA) advancing ProQR’s Axiomer™ ADAR-mediated RNA editing platform into clinical developmentLEIDEN, Netherlands & CAMBRIDGE, Mass., June 26, 2025 (GLOBE NEWSWIRE) — ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced the submission of a Clinical Trial Application (CTA) to the European Medicines Agency (EMA) to initiate a Phase 1 clinical trial of its lead pipeline program AX-0810 targeting NTCP, a liver cell protein that transports bile acids...

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, held today a shareholders general meeting at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France. At the meeting, during which approximately 57% of voting rights were exercised, resolutions 1 through 23 and resolutions 25 and 26 were adopted, while resolution 24 was rejected, consistent with the recommendations of the board of directors. The Cellectis shareholders’ meeting appointed Mr. André Muller as a member of the Company’s Board of Directors, with immediate effect. In addition, at the close of the AGM, the term of Mr Axel-Sven Malkomes expired, and the previously...